United States · FDA National Drug Code directory
MEDROXYPROGESTERONE ACETATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62756-091_10fdc3f5-de88-4bbb-9f3f-c0a0630d0222
- Product NDC
- 62756-091
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- MEDROXYPROGESTERONE ACETATE
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190501
- Source listing expiry
- 20261231
Source-listed ingredients
- MEDROXYPROGESTERONE ACETATE — 150 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE in 1 CARTON (62756-091-40) / 1 mL in 1 SYRINGE · 62756-091-40
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →